Total Payments
$18,805
2024 Payments
$2,886
Companies
59
Transactions
1,298
Medicare Patients
4,459
Medicare Billing
$410,571
Payment Breakdown by Category
Food & Beverage$18,764 (99.8%)
Education$40.69 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,764 | 1,293 | 99.8% |
| Education | $40.69 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,022 | 166 | $0 (2024) |
| ABBVIE INC. | $1,381 | 101 | $0 (2024) |
| Amgen Inc. | $1,319 | 82 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,314 | 72 | $0 (2024) |
| Lilly USA, LLC | $1,242 | 83 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,172 | 120 | $0 (2024) |
| PFIZER INC. | $942.31 | 74 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $824.35 | 41 | $0 (2022) |
| Astellas Pharma US Inc | $763.39 | 37 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $670.23 | 83 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,886 | 157 | Amgen Inc. ($307.31) |
| 2023 | $2,614 | 163 | AbbVie Inc. ($378.59) |
| 2022 | $2,729 | 190 | ABBVIE INC. ($348.99) |
| 2021 | $2,820 | 215 | Amgen Inc. ($278.15) |
| 2020 | $1,878 | 127 | Novo Nordisk Inc ($221.73) |
| 2019 | $2,188 | 153 | SANOFI-AVENTIS U.S. LLC ($231.96) |
| 2018 | $1,986 | 147 | Novo Nordisk Inc ($414.80) |
| 2017 | $1,705 | 146 | SANOFI-AVENTIS U.S. LLC ($200.71) |
All Payment Transactions
1,298 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $3.49 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Central Nervous System | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | NEXIUM (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Gastrointestinal | ||||||
| 12/10/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: Bone Health | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Cardio-renal | ||||||
| 11/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Obesity | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Neuroscience | ||||||
| 11/15/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Central Nervous System | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Biological | ||||||
| 11/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,584 | 2,132 | $334,340 | $150,433 |
| 2022 | 17 | 1,414 | 1,830 | $258,198 | $130,045 |
| 2021 | 12 | 811 | 1,181 | $121,415 | $75,845 |
| 2020 | 10 | 650 | 994 | $103,398 | $54,248 |
Total Patients
4,459
Total Services
6,137
Medicare Billing
$410,571
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 403 | 733 | $129,520 | $54,152 | 41.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 292 | 292 | $78,840 | $35,773 | 45.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 244 | 343 | $41,585 | $16,657 | 40.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 68 | $15,190 | $7,743 | 51.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 30 | 36 | $15,120 | $7,454 | 49.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 77 | 77 | $7,315 | $5,525 | 75.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $5,625 | $4,224 | 75.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 22 | 24 | $7,560 | $3,541 | 46.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 92 | 94 | $3,290 | $2,763 | 84.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $5,520 | $2,520 | 45.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $5,175 | $2,358 | 45.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 98 | 98 | $3,920 | $1,689 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $4,780 | $1,518 | 31.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $4,480 | $1,304 | 29.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 73 | 107 | $2,140 | $1,019 | 47.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $735.00 | $617.19 | 84.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 59 | $1,770 | $551.77 | 31.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 12 | $600.00 | $415.44 | 69.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 18 | 19 | $570.00 | $411.24 | 72.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 16 | $400.00 | $109.00 | 27.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 31 | 41 | $205.00 | $88.00 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 393 | 648 | $103,290 | $52,291 | 50.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 254 | 254 | $67,200 | $31,727 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 193 | 293 | $31,980 | $16,457 | 51.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 49 | $10,245 | $6,163 | 60.2% |
About Dr. Michael Carroll, MD
Dr. Michael Carroll, MD is a Family Medicine healthcare provider based in Traverse City, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346338324.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Carroll, MD has received a total of $18,805 in payments from pharmaceutical and medical device companies, with $2,886 received in 2024. These payments were reported across 1,298 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($18,764).
As a Medicare-enrolled provider, Carroll has provided services to 4,459 Medicare beneficiaries, totaling 6,137 services with total Medicare billing of $410,571. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Traverse City, MI
- Active Since 10/11/2006
- Last Updated 10/26/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1346338324
Products in Payments
- TRELEGY ELLIPTA (Drug) $905.87
- EMGALITY (Drug) $673.37
- REXULTI (Drug) $613.87
- QULIPTA (Drug) $564.84
- Ozempic (Drug) $507.92
- FARXIGA (Drug) $473.05
- TOUJEO (Drug) $461.27
- VRAYLAR (Drug) $458.06
- JARDIANCE (Drug) $421.23
- Aimovig (Biological) $415.36
- EVENITY (Biological) $381.48
- ELIQUIS (Drug) $381.17
- NUEDEXTA (Drug) $378.62
- Victoza (Drug) $366.29
- Kerendia (Drug) $360.38
- Saxenda (Drug) $337.35
- MYRBETRIQ (Drug) $335.41
- UBRELVY (Drug) $333.99
- SYMBICORT (Drug) $313.82
- Yupelri (Drug) $308.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Traverse City
Rafay Baig, M.d, M.D
Family Medicine — Payments: $155,076
Family Medicine $155,076
Dr. Kathryn Shaffer, M.d, M.D
Family Medicine — Payments: $22,044
Family Medicine $22,044
Rebecca Hoffman, D.o, D.O
Family Medicine — Payments: $11,980
Family Medicine $11,980
Gary Ruoff, D.o, D.O
Family Medicine — Payments: $8,245
Family Medicine $8,245
Patrick Friedli, M.d, M.D
Family Medicine — Payments: $5,991
Family Medicine $5,991
Sergei Shumaster
Family Medicine — Payments: $5,127
Family Medicine $5,127